LEONTIUS OF BYZANTIUM: A CYRILLIAN CHRISTOLOGYLYNCH J. J.THEOLOGICAL STUDIES. 1975, Vol 36, Num 3, pp 455-471Article

Prosopon in Gregory of Nyssa: A Theological Word in TransitionLYNCH, J. J.Theological Studies Baltimore, Md. 1979, Vol 40, Num 4, pp 728-738Article

Evelyn Waugh During the Pinfold YearsLYNCH, J. J.Modern fiction studies. 1986, Vol 32, Num 4, pp 543-559, issn 0026-7724Article

Moral Sense and the Narrator of Tom JonesLYNCH, J. J.Studies in English literature, 1500-1900. 1985, Vol 25, Num 3, pp 599-614, issn 0039-3657Article

Harrison and hick on God and animal painLYNCH, J. J.Sophia (Parkville). 1994, Vol 33, Num 3, pp 62-73, issn 0038-1527Article

EXP3174, the AII antagonist human metabolite of Losartan, but not Losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarctionLYNCH, J. J; STUMP, G. L; WALLACE, A. A et al.Journal of the American College of Cardiology. 1999, Vol 34, Num 3, pp 876-884, issn 0735-1097Article

Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templatesSANDERSON, P. E. J; LYLE, T. A; COOPER, C. M et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 23, pp 4466-4474, issn 0022-2623Article

Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 positionFENG, D.-M; GARDELL, S. J; LYNCH, J. J et al.Journal of medicinal chemistry (Print). 1997, Vol 40, Num 23, pp 3726-3733, issn 0022-2623Article

Gh replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarctionSHEN, Y.-T; WIEDMANN, R. T; LYNCH, J. J et al.American journal of physiology. Heart and circulatory physiology. 1996, Vol 40, Num 5, pp H1721-H1727, issn 0363-6135Article

Techniques to assess the various factors affecting the long term dimensional stability of rigid polyurethane foamSINGH, S. N; LYNCH, J. J; DAEMS, D et al.Journal of cellular plastics. 1996, Vol 32, Num 6, issn 0021-955X, 520, 553-578 [27 p.]Conference Paper

Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro[(2H)-1-benzopyran-2,4'-piperidin]-4-one HCI (L-691,121), a novel class III agentLYNCH, J. J; WALLACE, A. A; JURKIEWICZ, N. K et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 265, Num 2, pp 720-730, issn 0022-3565Article

The simulation of enhanced oil recovery processes using a vapor/liquid equilibrium model based on critical scaling theorySAMS, W. N; LYNCH, J. J; SMITH, D. H et al.Symposium on Reservoir Simulation. 1993, pp 249-260Conference Paper

Cardiovascular responses of patients with cardiac disease to talking and exercise stress testingTHOMAS, S. A; FREED, C. D; FRIEDMANN, E et al.Heart & lung. 1992, Vol 21, Num 1, pp 64-73, issn 0147-9563Article

Increased endothelial albumin permeability mediated by protein kinase C activationLYNCH, J. J; FERRO, T. J; BLUMENSTOCK, F. A et al.The Journal of clinical investigation. 1990, Vol 85, Num 6, pp 1991-1998, issn 0021-9738Article

Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacingUPRICHARD, A. C. G; LIGUO CHI; LYNCH, J. J et al.Journal of cardiovascular pharmacology. 1989, Vol 14, Num 3, pp 475-482, issn 0160-2446Article

Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite 625671ELLER, B. T; LYNCH, J. J; PATTERSON, E et al.Pharmacology. 1987, Vol 34, Num 2-3, pp 121-130, issn 0031-7012Article

Effects of flecainide acetate on ventricular trachyarrhythmia and fibrillation in dogs with recent myocardial infarctionLYNCH, J. J; DI CARLO, L. A; MONTGOMERY, D. G et al.Pharmacology. 1987, Vol 35, Num 4, pp 181-193, issn 0031-7012Article

Cardiac electrophysiologic actions of SCH 19927 (Dilevalol), the R,R-isomer of labetalolLYNCH, J. J; MONTGOMERY, D. G; LUCCHESI, B. R et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 239, Num 3, pp 719-723, issn 0022-3565Article

Prevalence of right-to-left atrial shunting in a healthy population: Detection by Valsalva maneuver contrast echocardiographyLYNCH, J. J; SCHUCHARD, G. H; GROSS, C. M et al.The American journal of cardiology. 1984, Vol 53, Num 10, pp 1478-1480, issn 0002-9149Article

Evaluating occupational therapy psychiatric care through medical documentationLYNCH, J. J; STEIN, F.Occupational therapy in mental health. 1986, Vol 6, Num 3, pp 53-66, issn 0164-212XArticle

Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeysLYNCH, J. J; WILSON, A. W; HERNANDEZ, L. E et al.British journal of pharmacology. 2008, Vol 154, Num 7, pp 1439-1445, issn 0007-1188, 7 p.Article

Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, I_Ks, in canine models of malignant ischemic ventricular arrhythmiaLYNCH, J. J; HOULE, M. S; CLAREMON, D. A et al.Circulation (New York, N.Y.). 1999, Vol 100, Num 18, pp 1917-1922, issn 0009-7322Article

Discovery and development of the novel potent orally active thrombin inhibitor N-(9-hydroxy-9-fluorenecarboxy)prolyl trans-4-aminocyclohexylmethyl amide (L-372,460) : Coapplication of structure-based design and rapid multiple analogue synthesis on solid supportBRADY, S. F; STAUFFER, K. J; COOK, J. J et al.Journal of medicinal chemistry (Print). 1998, Vol 41, Num 3, pp 401-406, issn 0022-2623Article

Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failureSHEN, Y.-T; WOLTMANN, R. F; APPLEBY, S et al.American journal of physiology. Heart and circulatory physiology. 1998, Vol 43, Num 2, pp H456-H466, issn 0363-6135Article

Class III antiarrhythmic activity in vivo by selective blockade of the slowly activating cardiac delayed rectifier potassium current I_Ks by (R)-2-(2,4-trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamideSELNICK, H. G; LIVERTON, N. J; PRIBUSH, D. A et al.Journal of medicinal chemistry (Print). 1997, Vol 40, Num 24, pp 3865-3868, issn 0022-2623Article